An increased NM23HJ copy number may be a poor prognostic factor independent of LOH on lp in neuroblastomas
1996

Increased NM23H1 Copy Number as a Prognostic Factor in Neuroblastomas

Sample size: 154 publication Evidence: moderate

Author Information

Author(s): Takedal, M Handa, T Uehara, N Maseki, A Sakashita, M Sakurai, N Kanda, Y Arai, Y Kaneko

Primary Institution: Saitama Cancer Center Hospital

Hypothesis

An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on lp in neuroblastomas.

Conclusion

The study suggests that an increased NM23H1 copy number may predict poor prognosis in neuroblastoma patients.

Supporting Evidence

  • Event-free survival (EFS) was significantly shorter in patients with LOH on lp compared to those without.
  • Patients with increased NM23H1 copy numbers had a shorter EFS than those with normal copy numbers.
  • Most tumors with increased NM23H1 copy numbers occurred in patients aged 12 months or more.

Takeaway

This study found that having more copies of a specific gene (NM23H1) in neuroblastoma tumors can mean a worse outcome for kids with this cancer.

Methodology

The study analyzed tissue samples from 154 neuroblastomas for loss of heterozygosity (LOH) and NM23H1 copy number, correlating these with event-free survival (EFS).

Limitations

The study may have included a large number of patients found by mass screening, which could affect the incidence rates reported.

Participant Demographics

Patients were Japanese infants and children aged between 10 days and 9 years.

Statistical Information

P-Value

0.0093

Statistical Significance

p=0.0093

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication